Literature DB >> 20458021

Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies.

Stephen L Archer1, E Kenneth Weir, Martin R Wilkins.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20458021      PMCID： PMC2869481          DOI： 10.1161/CIRCULATIONAHA.108.847707

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  196 in total

Review 1.  NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential.

Authors:  Oleg V Evgenov; Pál Pacher; Peter M Schmidt; György Haskó; Harald H H W Schmidt; Johannes-Peter Stasch
Journal:  Nat Rev Drug Discov       Date:  2006-09       Impact factor: 84.694

2.  HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques.

Authors:  John C Marecki; Carlyne D Cool; Jane E Parr; Virginia E Beckey; Paul A Luciw; Alice F Tarantal; Angela Carville; Richard P Shannon; Adela Cota-Gomez; Rubin M Tuder; Norbert F Voelkel; Sonia C Flores
Journal:  Am J Respir Crit Care Med       Date:  2006-05-25       Impact factor: 21.405

3.  Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial.

Authors:  L J Rubin; J Mendoza; M Hood; M McGoon; R Barst; W B Williams; J H Diehl; J Crow; W Long
Journal:  Ann Intern Med       Date:  1990-04-01       Impact factor: 25.391

4.  Polyamines and the development of monocrotaline-induced pulmonary hypertension.

Authors:  J W Olson; A D Hacker; R J Altiere; M N Gillespie
Journal:  Am J Physiol       Date:  1984-10

5.  Primary pulmonary hypertension: natural history and the importance of thrombosis.

Authors:  V Fuster; P M Steele; W D Edwards; B J Gersh; M D McGoon; R L Frye
Journal:  Circulation       Date:  1984-10       Impact factor: 29.690

6.  Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension.

Authors:  Steven M Kawut; Evelyn M Horn; Ketevan K Berekashvili; David J Lederer; Allison C Widlitz; Erika B Rosenzweig; Robyn J Barst
Journal:  Pulm Pharmacol Ther       Date:  2006-02-17       Impact factor: 3.410

7.  Microvascular regeneration in established pulmonary hypertension by angiogenic gene transfer.

Authors:  Yidan D Zhao; David W Courtman; Doug S Ng; Malcolm J Robb; Yupu P Deng; Judy Trogadis; Robin N N Han; Duncan J Stewart
Journal:  Am J Respir Cell Mol Biol       Date:  2006-03-16       Impact factor: 6.914

8.  Mechanisms for increased glycolysis in the hypertrophied rat heart.

Authors:  Luigino Nascimben; Joanne S Ingwall; Beverly H Lorell; Ilka Pinz; Vera Schultz; Keith Tornheim; Rong Tian
Journal:  Hypertension       Date:  2004-10-04       Impact factor: 10.190

9.  High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.

Authors:  S Rich; B H Brundage
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

10.  Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

Authors:  D J Stewart; R D Levy; P Cernacek; D Langleben
Journal:  Ann Intern Med       Date:  1991-03-15       Impact factor: 25.391
View more
  185 in total

1.  Visceral adipose tissue-derived serine protease inhibitor prevents the development of monocrotaline-induced pulmonary arterial hypertension in rats.

Authors:  Yuzaburo Sakamoto; Satoshi Kameshima; Chiharu Kakuda; Yuta Okamura; Tomoko Kodama; Muneyoshi Okada; Hideyuki Yamawaki
Journal:  Pflugers Arch       Date:  2017-08-03       Impact factor: 3.657

Review 2.  Targeting soluble guanylate cyclase for the treatment of pulmonary hypertension.

Authors:  George F Lasker; Jason H Maley; Edward A Pankey; Philip J Kadowitz
Journal:  Expert Rev Respir Med       Date:  2011-04       Impact factor: 3.772

3.  A chocolate a day keeps the doctor away?

Authors:  Christopher F Barnett; Teresa De Marco
Journal:  J Physiol       Date:  2011-12-15       Impact factor: 5.182

4.  The A2B adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease.

Authors:  Harry Karmouty-Quintana; Hongyan Zhong; Luis Acero; Tingting Weng; Ernestina Melicoff; James D West; Anna Hemnes; Almut Grenz; Holger K Eltzschig; Timothy S Blackwell; Yang Xia; Richard A Johnston; Dewan Zeng; Luiz Belardinelli; Michael R Blackburn
Journal:  FASEB J       Date:  2012-03-13       Impact factor: 5.191

Review 5.  The role of mitochondria in pulmonary vascular remodeling.

Authors:  Peter Dromparis; Gopinath Sutendra; Evangelos D Michelakis
Journal:  J Mol Med (Berl)       Date:  2010-08-24       Impact factor: 4.599

Review 6.  Strategic plan for lung vascular research: An NHLBI-ORDR Workshop Report.

Authors:  Serpil Erzurum; Sharon I Rounds; Troy Stevens; Micheala Aldred; Jason Aliotta; Stephen L Archer; Kewal Asosingh; Robert Balaban; Natalie Bauer; Jahar Bhattacharya; Harm Bogaard; Gaurav Choudhary; Gerald W Dorn; Raed Dweik; Karen Fagan; Michael Fallon; Toren Finkel; Mark Geraci; Mark T Gladwin; Paul M Hassoun; Marc Humbert; Naftali Kaminski; Steven M Kawut; Joseph Loscalzo; Donald McDonald; Ivan F McMurtry; John Newman; Mark Nicolls; Marlene Rabinovitch; Judy Shizuru; Masahiko Oka; Peter Polgar; David Rodman; Paul Schumacker; Kurt Stenmark; Rubin Tuder; Norbert Voelkel; Eugene Sullivan; Richard Weinshilboum; Mervin C Yoder; Yingming Zhao; Dorothy Gail; Timothy M Moore
Journal:  Am J Respir Crit Care Med       Date:  2010-09-10       Impact factor: 21.405

7.  Dysregulation of miR-135a-5p promotes the development of rat pulmonary arterial hypertension in vivo and in vitro.

Authors:  Hong-Mei Liu; Yi Jia; Ying-Xian Zhang; Jun Yan; Ning Liao; Xiao-Hui Li; Yuan Tang
Journal:  Acta Pharmacol Sin       Date:  2018-07-23       Impact factor: 6.150

8.  Increased TMEM16A-encoded calcium-activated chloride channel activity is associated with pulmonary hypertension.

Authors:  Abigail S Forrest; Talia C Joyce; Marissa L Huebner; Ramon J Ayon; Michael Wiwchar; John Joyce; Natalie Freitas; Alison J Davis; Linda Ye; Dayue D Duan; Cherie A Singer; Maria L Valencik; Iain A Greenwood; Normand Leblanc
Journal:  Am J Physiol Cell Physiol       Date:  2012-10-03       Impact factor: 4.249

9.  Protective effects of 10-nitro-oleic acid in a hypoxia-induced murine model of pulmonary hypertension.

Authors:  Anna Klinke; Annika Möller; Michaela Pekarova; Thorben Ravekes; Kai Friedrichs; Matthias Berlin; Katrin M Scheu; Lukas Kubala; Hana Kolarova; Gabriela Ambrozova; Ralph T Schermuly; Steven R Woodcock; Bruce A Freeman; Stephan Rosenkranz; Stephan Baldus; Volker Rudolph; Tanja K Rudolph
Journal:  Am J Respir Cell Mol Biol       Date:  2014-07       Impact factor: 6.914

Review 10.  Oxidative modulation of voltage-gated potassium channels.

Authors:  Nirakar Sahoo; Toshinori Hoshi; Stefan H Heinemann
Journal:  Antioxid Redox Signal       Date:  2013-10-26       Impact factor: 8.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.